HULSIK; David Lutje
Patent Applications and Registrations
Patent applications and USPTO patent grants for HULSIK; David Lutje.The latest application filed is for "anti-sirp alpha antibodies".
- HULSIK; David Lutje - Oss NL
- HULSIK; David Lutje - ROTTERDAM NL
- Hulsik; David Lutje - Nijmegen NL
| Patent | Date |
|---|---|
| Anti-sirp Alpha Antibodies App 20220135671 - VAN EENENNAAM; Hans ; et al. | 2022-05-05 |
| Anti-sirp Alpha Antibodies App 20220135677 - VAN EENENNAAM; Hans ; et al. | 2022-05-05 |
| Altered April Binding Antibodies App 20210221900 - Van Eenennaam; Hans ; et al. | 2021-07-22 |
| Humanized antibodies which bind to human APRIL ("a proliferation-inducing ligand") Grant 10,961,316 - van Eenennaam , et al. March 30, 2 | 2021-03-30 |
| Anti-SIRP.alpha. antibodies Grant 10,851,164 - Van Eenennaam , et al. December 1, 2 | 2020-12-01 |
| Anti-HCTLA-4 antibodies Grant 10,808,030 - Van Eenennaam , et al. October 20, 2 | 2020-10-20 |
| Altered April Binding Antibodies App 20200079859 - van Eenennaam; Hans ; et al. | 2020-03-12 |
| Anti-PD-1 antibodies Grant 10,494,436 - Van Eenennaam , et al. De | 2019-12-03 |
| Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies Grant 10,377,830 - van Eenennaam , et al. A | 2019-08-13 |
| Anti-sirp Alpha Antibodies App 20180312587 - VAN EENENNAAM; Hans ; et al. | 2018-11-01 |
| Altered April Binding Antibodies App 20180258176 - van Eenennaam; Hans ; et al. | 2018-09-13 |
| Altered APRIL binding antibodies Grant 9,969,808 - van Eenennaam , et al. May 15, 2 | 2018-05-15 |
| New Anti-hctla-4 Antibodies App 20180037654 - VAN EENENNAAM; Hans ; et al. | 2018-02-08 |
| Anti-pd-1 Antibodies App 20180030137 - VAN EENENNAAM; Hans ; et al. | 2018-02-01 |
| Altered April Binding Antibodies App 20160264674 - van Eenennaam; Hans ; et al. | 2016-09-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 